[ Price : $8.95]
FDA approves a Respicardia PMA for the Remed System as a treatment option for patients who have been diagnosed with moderate to se...[ Price : $8.95]
FDA clears a Roche 510(k) for the Cobas C-diff Nucleic acid test for detecting the toxin B gene of toxigenic Clostridium difficile...[ Price : $8.95]
FDA accepts an Amgen supplemental BLA for Prolia (denosumab) for treating patients with glucocorticoid-induced osteoporosis.[ Price : $8.95]
FDA grants AstraZeneca a breakthrough therapy designation for Tagrisso (osimertinib) for the first-line treatment of patients with...[ Price : $8.95]
FDA awards six new research grants ($6.3 million) for natural history studies in rare diseases that are intended to evaluate how t...[ Price : $8.95]
Federal Register notice: FDA announces a 11/2 public meeting entitled Animal Generic Drug User Fee Act.[ Price : $8.95]
FDA clears a Game Ready 510(k) for its orthopedic rehabilitation device, the Med4 Elite.[ Price : $8.95]
Federal Register notice: FDA announces a 11/2 public meeting entitled Animal Drug User Fee Act.